TWAPF (TOWA Pharmaceutical Co) Accounts Payable: $156 Mil (As of Mar. 2026)


TWAPF TOWA Pharmaceutical Co Ltd TWAPF
86 GF Score
Price $26.00
GF Value $14.43
! 7 Warning Signs
View Full Analysis

What is TOWA Pharmaceutical Co Accounts Payable?

TOWA Pharmaceutical Co TWAPF +1.13% 86 Accounts Payable is $156 Mil as of Mar. 2026. GuruFocus rates TWAPF with a GF Score™ of 86/100 and a GF Value™ of $14.43. The stock has 7 warning signs investors should review.

TOWA Pharmaceutical Co's Accounts Payable for the quarter that ended in Mar. 2026 was $156 Mil.

TOWA Pharmaceutical Co's quarterly Accounts Payable increased from Sep. 2025 ($108 Mil) to Dec. 2025 ($123 Mil) and increased from Dec. 2025 ($123 Mil) to Mar. 2026 ($156 Mil).

TOWA Pharmaceutical Co's annual Accounts Payable increased from Mar. 2024 ($170 Mil) to Mar. 2025 ($181 Mil) but then declined from Mar. 2025 ($181 Mil) to Mar. 2026 ($156 Mil).

TOWA Pharmaceutical Co Accounts Payable Related Terms

TOWA Pharmaceutical Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for TOWA Pharmaceutical Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TOWA Pharmaceutical Co Accounts Payable Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 172.61 234.05 169.67 181.07 156.46

TOWA Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 181.07 127.20 108.36 122.94 156.46
TWAPF
86GF Score
TOWA Pharmaceutical Co Ltd TWAPF
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TOWA Pharmaceutical Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $156 Mil mean?
TOWA Pharmaceutical Co (TWAPF) has a Accounts Payable of $156 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on TOWA Pharmaceutical Co and its competitors.
Is TOWA Pharmaceutical Co's Accounts Payable too high?
TOWA Pharmaceutical Co's current Accounts Payable is $156 Mil. Overall, TOWA Pharmaceutical Co has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's Accounts Payable compare to ZTS and UTHR?
TOWA Pharmaceutical Co's Accounts Payable of $156 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on TOWA Pharmaceutical Co and its competitors. TOWA Pharmaceutical Co's current Accounts Payable is $156 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
TOWA Pharmaceutical Co (TWAPF) has a current Accounts Payable of $156 Mil. The stock's GF Value™ is $14.43, compared to a current price of $26.00 — trading 80.2% above its estimated fair value. The current Accounts Payable is $156 Mil. TOWA Pharmaceutical Co's overall GF Score™ is 86/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For TOWA Pharmaceutical Co (TWAPF), the current Accounts Payable is $156 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TOWA Pharmaceutical Co (TWAPF) Overvalued in 2026?

Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued. The current stock price of $26.00 is trading 80.2% above its estimated GF Value™ of $14.43.

Key valuation signals for TWAPF:

  • Accounts Payable: $156 Mil
  • GF Value™: $14.43 vs. price of $26.00 (80.2% above fair value)
  • GF Score™: 86/100 with 7 warning signs

No single metric tells the full story. See the TWAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TOWA Pharmaceutical Co Business Description

Other Exchanges 4553:Japan6QC:Germany
Address 2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
86GF Score

Get the complete analysis for TWAPF

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.00
Price
$14.43
GF Value